Current Hematologic Malignancy Reports

13.4k citations
819 papers · · active since 2016

Impact in

  • Hematology top 5%
    • Acute Myeloid Leukemia Research
    • Chronic Myeloid Leukemia Treatments
    • Multiple Myeloma Research and Treatments
  • Genetics top 5%
    • Chronic Lymphocytic Leukemia Research
    • Myeloproliferative Neoplasms: Diagnosis and Treatment

Papers in

    • Acute Myeloid Leukemia Research 206
    • Chronic Myeloid Leukemia Treatments 169
    • Chronic Lymphocytic Leukemia Research 191
    • Myeloproliferative Neoplasms: Diagnosis and Treatment 132

Current Hematologic Malignancy Reports

771 papers receiving 12.7k citations

Peers

Current Hematologic Malignancy Reports
Comparison fields: 5 of 156
  • Hematology 4.8k
  • Genetics 3.6k
  • Pathology and Forensic Medicine 2.5k
  • Oncology 3.6k
  • Immunology 1.8k
Replace Therapeutic Advances in Hematology with:
Therapeutic Advances in Hematology United States
Mediterranean Journal of Hematology and Infectious Diseases Italy
Critical Reviews in Clinical Laboratory Sciences United States
Experimental Hematology and Oncology China
Archivum Immunologiae et Therapiae Experimentalis Poland
Biomarker Research China
Hematology/Oncology and Stem Cell Therapy United States
Molecular Pathology United Kingdom
Diagnostic Molecular Pathology United States
International Reviews of Immunology United States
Current Hematologic Malignancy Reports relative to Therapeutic Advances in Hematology United States Therapeutic Advances in Hematology's profile →
Citations per field
00.5×1.5×2.0×
Therapeutic Advances in Hematology · 1×
Citations per year

Countries where authors publish in Current Hematologic Malignancy Reports

Since Specialization
Citations

This map shows the geographic impact of research published in Current Hematologic Malignancy Reports. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers published in Current Hematologic Malignancy Reports with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Current Hematologic Malignancy Reports more than expected).

Fields of papers published in Current Hematologic Malignancy Reports

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers published in Current Hematologic Malignancy Reports. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers published in Current Hematologic Malignancy Reports.

About Current Hematologic Malignancy Reports

The 819 papers published in Current Hematologic Malignancy Reports in the last decades have received a total of 13.4k indexed citations . Papers published in Current Hematologic Malignancy Reports usually cover Hematology (408 papers), Genetics (334 papers), Pathology and Forensic Medicine (219 papers), Oncology (207 papers) and Rheumatology (80 papers) specifically the topics of Lymphoma Diagnosis and Treatment (214 papers), Acute Myeloid Leukemia Research (206 papers), Chronic Lymphocytic Leukemia Research (191 papers), Chronic Myeloid Leukemia Treatments (169 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (132 papers), Acute Lymphoblastic Leukemia research (132 papers), CAR-T cell therapy research (81 papers) and Eosinophilic Disorders and Syndromes (78 papers). The most active scholars publishing in Current Hematologic Malignancy Reports are Jan A. Burger, David P. Steensma, Christopher Ramin Cogle, Joseph David Khoury, Giovanni Barosi, Jennifer R. Brown, Naveen Pemmaraju, Zeina Al‐Mansour, Beverly P. Nelson and Andrew M. Evens.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore journals with similar magnitude of impact